Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient-caregiver dyad perspective
- PMID: 33835372
- DOI: 10.1007/s11096-021-01264-9
Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient-caregiver dyad perspective
Abstract
Background Medication adherence is essential in the management of schizophrenia. Yet poor treatment uptake has negative consequences on patients and their primary caregivers. Objective To examine the association among beliefs about psychotropic medications, side effects and adherence from a patient-caregiver dyad perspective. Setting This study was conducted in a public psychiatric hospital setting in Accra, Ghana. Methods A cross-sectional study was conducted among 121 patient-caregiver dyads using an interviewer-administered data collection approach.Main outcome measure Beliefs about medicines, side-effects and medication adherence. Results The patient and caregiver-reported level of medication adherence was 28.1 %. Using the Kappa index, the level of agreement between the responses of patients and their caregivers ranged from slight to moderate. Both patients and caregivers rated necessity higher than concern (patients: 1.67 ± 0.84, caregiver: 1.79 ± 0.96). Significant positive relations between specific-necessity, necessity-concerns differential and medication adherence were recorded while specific-concern, general harm and side-effects correlated negatively with medication adherence from the dyad. The odds of adhering to medications increased by 58 and 64 % for each unit increase in specific-necessity and general overuse scores respectively. However, a unit increase in specific-concern score and high side-effects scores were associated with lower odds of adherence. Conclusions This study highlights the need for patient-caregiver collaborations in decision-making relating to medication adherence in schizophrenia. Thus, in clinical practice, there is the need to recognize that caregivers are essential partners, and patient-caregiver views about psychotropic medications are critical in enhancing adherence for positive mental health outcomes.
Keywords: Beliefs; Caregivers; Ghana; Medication adherence; Psychotropic medications; Schizophrenia.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.Psychiatry Res. 2018 Jan;259:289-294. doi: 10.1016/j.psychres.2017.10.034. Epub 2017 Oct 24. Psychiatry Res. 2018. PMID: 29091831
-
Factors associated with medication non-adherence among patients with severe mental disorder - A cross sectional study in a tertiary care centre.Explor Res Clin Soc Pharm. 2022 Sep 12;7:100178. doi: 10.1016/j.rcsop.2022.100178. eCollection 2022 Sep. Explor Res Clin Soc Pharm. 2022. PMID: 36161207 Free PMC article.
-
Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.Eur Child Adolesc Psychiatry. 2017 May;26(5):559-571. doi: 10.1007/s00787-016-0919-1. Epub 2016 Nov 15. Eur Child Adolesc Psychiatry. 2017. PMID: 27848023 Free PMC article.
-
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.Syst Rev. 2020 Jan 16;9(1):17. doi: 10.1186/s13643-020-1274-3. Syst Rev. 2020. PMID: 31948489 Free PMC article.
-
Necessity and concerns beliefs and HIV medication adherence: a systematic review.J Behav Med. 2020 Feb;43(1):1-15. doi: 10.1007/s10865-019-00089-2. Epub 2019 Aug 8. J Behav Med. 2020. PMID: 31396819
Cited by
-
The Interrelationship of Benefit Finding, Stigma, and Suicide Risk Among Patients with Schizophrenia and Their Caregivers: A Six-Month Follow-Up Study.Healthcare (Basel). 2024 Oct 31;12(21):2176. doi: 10.3390/healthcare12212176. Healthcare (Basel). 2024. PMID: 39517388 Free PMC article.
-
Sentiment analysis in medication adherence: using ruled-based and artificial intelligence-driven algorithms to understand patient medication experiences.Int J Clin Pharm. 2025 Aug;47(4):970-980. doi: 10.1007/s11096-024-01803-0. Epub 2024 Oct 4. Int J Clin Pharm. 2025. PMID: 39365522
References
-
- Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21:1–7. - DOI
-
- World Health Organization. Mental health, Ghana. 2021. https://www.who.int/mental_health/policy/country/ghana/en/ . Accessed Feb 9 2021.
-
- Awad AG, Voruganti LN. The burden of schizophrenia on caregivers. Pharmacoeconomics. 2008;2:149–62. - DOI
-
- Roberts M, Mogan C, Asare JB. An overview of Ghana’s mental health system: results from an assessment using the World Health Organization’s Assessment Instrument for Mental Health Systems (WHO-AIMS). Int J Ment Health Syst. 2014;8:1–3. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical